Economic portfolio
PGIM INDIA HEALTHCARE FUND
PGIM PGIM India Mutual Fund May 2025 — Sep 2026 17 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.4 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
17 priced months, May 2025 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
60.3% now, 62.4% in Sep 2025 · highest 69.0%, lowest 60.3%
Companies held
31 now, 30 in Sep 2025 · largest single holding 10.9% of equity
How it trades: no clear lean toward recent winners or losers (score +0.11 over 8 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 22 shared56.1%
- Mirae Asset Healthcare FundMirae Asset · 17 shared55.0%
- HDFC Pharma and Healthcare FundHDFC · 19 shared54.6%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 21 shared53.8%
- ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 17 shared51.4%
- EODWHFEdelweiss · 15 shared51.0%
- Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 16 shared50.9%
- SBI Healthcare Opportunities FundSBI · 17 shared50.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 IPCA Laboratories Limited+304.7% +9,780
- 02 Fortis Healthcare Limited+62.5% +9,480
- 03 Zydus Lifesciences Limited+40.8% +6,630
- 04 Max Healthcare Institute Limited+10.9% +6,490
- 05 ICICI Lombard General Insurance Company Limited+54.3% +6,060
- 06 Sun Pharmaceutical Industries Limited+8.6% +5,820
- 07 Lenskart Solutions Limited+38.9% +5,250
- 08 Lupin Limited+52.7% +4,280
- 09 Gland Pharma Limited+111.8% +3,550
- 10 Dr. Lal Path Labs Ltd.+11.7% +2,970
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.92% | 13.50 Cr | 14,529 | by May 2025 (17 mo+) |
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 10.80% | 13.35 Cr | 73,508 | by May 2025 (17 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 8.95% | 11.06 Cr | 23,046 | by May 2025 (17 mo+) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 5.23% | 6.46 Cr | 17,855 | by May 2025 (17 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 4.97% | 6.14 Cr | 66,054 | by May 2025 (17 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 4.56% | 5.64 Cr | 28,402 | by May 2025 (17 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 4.26% | 5.27 Cr | 21,045 | by May 2025 (17 mo+) |
| Manipal Health Enterprises Limited | Not classified | — | 3.87% | 4.79 Cr | 67,646 | Jul 2026 (3 mo) |
| Navin Fluorine International Limited | Chemicals | Small Cap | 3.42% | 4.22 Cr | 5,122 | by May 2025 (17 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 3.29% | 4.06 Cr | 1,498 | by May 2025 (17 mo+) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 3.15% | 3.90 Cr | 52,247 | by May 2025 (17 mo+) |
| Rubicon Research Limited | Healthcare | Small Cap | 3.15% | 3.90 Cr | 24,070 | Oct 2025 (12 mo) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 3.06% | 3.79 Cr | 1,774 | by May 2025 (17 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 2.70% | 3.34 Cr | 47,891 | by May 2025 (17 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 2.68% | 3.32 Cr | 21,756 | by May 2025 (17 mo+) |
| ICICI Lombard General Insurance Company Limited | Financial Services | Mid Cap | 2.21% | 2.74 Cr | 17,223 | by May 2025 (17 mo+) |
| Cipla Limited | Healthcare | Large Cap | 2.15% | 2.66 Cr | 19,771 | by May 2025 (17 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.15% | 2.66 Cr | 22,885 | Jun 2026 (4 mo) |
| Lupin Limited | Healthcare | Mid Cap | 2.04% | 2.52 Cr | 12,400 | Apr 2026 (6 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.02% | 2.50 Cr | 12,990 | Aug 2026 (2 mo) |
| Dr Agarwals Eye Hospital Limited | Not classified | Small Cap | 1.96% | 2.42 Cr | 4,726 | by May 2025 (17 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 1.91% | 2.36 Cr | 27,457 | Jul 2025 (15 mo) |
| Global Health Limited | Healthcare | Mid Cap | 1.61% | 1.99 Cr | 14,551 | by May 2025 (17 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 1.58% | 1.95 Cr | 6,725 | Aug 2026 (2 mo) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 1.54% | 1.90 Cr | 74,950 | by May 2025 (17 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 1.53% | 1.90 Cr | 24,640 | Apr 2026 (6 mo) |
| Symbiotec Pharmalab Limited | Not classified | — | 1.16% | 1.43 Cr | 12,158 | Sep 2026 (1 mo) |
| Lenskart Solutions Limited | Consumer Services | Mid Cap | 1.04% | 1.28 Cr | 18,751 | Oct 2025 (12 mo) |
| Molbio Diagnostics Limited | Not classified | — | 0.84% | 1.04 Cr | 7,977 | Sep 2026 (1 mo) |
| Orchid Pharma Limited | Not classified | Small Cap | 0.83% | 1.03 Cr | 10,285 | by May 2025 (17 mo+) |
| SAGILITY LIMITED | Information Technology | Small Cap | 0.42% | 0.52 Cr | 0.01 Cr | by May 2025 (17 mo+) |
Half of its current holdings have been held for 17 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Dr. Agarwal's Health Care Limited | Sep 2026 | ▼ Complete exit | -20,940 |
| Symbiotec Pharmalab Limited | Sep 2026 | ▲ New position | +12,158 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +9,780 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +9,480 |
| Molbio Diagnostics Limited | Sep 2026 | ▲ New position | +7,977 |
| Zydus Lifesciences Limited | Sep 2026 | ▲ Increasing | +6,630 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +6,490 |
| ICICI Lombard General Insurance Company Limited | Sep 2026 | ▲ Increasing | +6,060 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +5,820 |
| Pfizer Limited | Sep 2026 | ▼ Complete exit | -5,665 |
| Lenskart Solutions Limited | Sep 2026 | ▲ Increasing | +5,250 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +4,280 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +3,550 |
| Rubicon Research Limited | Sep 2026 | ▼ Reducing | -3,520 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +2,970 |
| Dr Agarwals Eye Hospital Limited | Sep 2026 | ▲ Increasing | +1,882 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +1,160 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +1,090 |
| Navin Fluorine International Limited | Sep 2026 | ▲ Increasing | +730 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +190 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +130 |
| Manipal Health Enterprises Limited | Aug 2026 | ▲ Increasing | +49,396 |
| Aster DM Quality Care Limited | Aug 2026 | ▼ Reducing | -36,488 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +6,790 |
| ICICI Lombard General Insurance Company Limited | Aug 2026 | ▲ Increasing | +5,045 |
| IPCA Laboratories Limited | Aug 2026 | ▲ New position | +3,210 |
| Gland Pharma Limited | Aug 2026 | ▲ New position | +3,175 |
| Zydus Lifesciences Limited | Aug 2026 | ▲ Increasing | +2,900 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +2,430 |
| Dr Agarwals Eye Hospital Limited | Aug 2026 | ▲ Increasing | +1,850 |
| Dr. Lal Path Labs Ltd. | Aug 2026 | ▲ Increasing | +1,700 |
| Cipla Limited | Aug 2026 | ▲ Increasing | +1,660 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +1,446 |
| Pfizer Limited | Aug 2026 | ▲ Increasing | +450 |
| Navin Fluorine International Limited | Aug 2026 | ▲ Increasing | +240 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +70 |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -28,785 |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▼ Complete exit | -20,021 |
| Manipal Health Enterprises Limited | Jul 2026 | ▲ New position | +18,250 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +14,680 |
| Dr. Lal Path Labs Ltd. | Jul 2026 | ▲ Increasing | +4,312 |
| Rubicon Research Limited | Jul 2026 | ▼ Reducing | -1,780 |
| Pfizer Limited | Jul 2026 | ▲ Increasing | +1,367 |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▲ Increasing | +710 |
| Abbott India Limited | Jul 2026 | ▲ Increasing | +260 |
| Rubicon Research Limited | Jun 2026 | ▼ Reducing | -27,310 |
| Zydus Lifesciences Limited | Jun 2026 | ▲ New position | +13,355 |
| Max Healthcare Institute Limited | Jun 2026 | ▲ Increasing | +10,363 |
| PB Fintech Limited | Jun 2026 | ▼ Complete exit | -7,678 |
| Cipla Limited | Jun 2026 | ▲ Increasing | +6,989 |
| Ajanta Pharma Limited | Jun 2026 | ▲ Increasing | +1,505 |
| Pfizer Limited | Jun 2026 | ▲ Increasing | +1,108 |
| Fortis Healthcare Limited | Apr 2026 | ▲ New position | +15,160 |
| Aster DM Quality Care Limited | Apr 2026 | ▼ Reducing | -11,110 |
| Dr. Reddy's Laboratories Limited | Apr 2026 | ▼ Reducing | -6,760 |
| Lupin Limited | Apr 2026 | ▲ New position | +5,690 |
| Rubicon Research Limited | Apr 2026 | ▼ Reducing | -3,280 |
| Pfizer Limited | Apr 2026 | ▲ Increasing | +1,035 |
| SAGILITY LIMITED | Mar 2026 | ▼ Reducing | -31,050 |
| Dr. Reddy's Laboratories Limited | Mar 2026 | ▼ Reducing | -16,990 |
| Dr. Agarwal's Health Care Limited | Mar 2026 | ▲ Increasing | +11,440 |
| Sai Life Sciences Limited | Mar 2026 | ▼ Reducing | -5,880 |
| Aster DM Quality Care Limited | Mar 2026 | ▼ Reducing | -4,350 |
| Rubicon Research Limited | Mar 2026 | ▼ Reducing | -2,760 |
| Sun Pharmaceutical Industries Limited | Mar 2026 | ▼ Reducing | -2,010 |
| Krishna Institute of Medical Sciences Limited | Mar 2026 | ▼ Reducing | -1,740 |
| Pfizer Limited | Mar 2026 | ▲ New position | +1,705 |
| Global Health Limited | Mar 2026 | ▼ Reducing | -1,300 |
| Torrent Pharmaceuticals Limited | Mar 2026 | ▼ Reducing | -1,000 |
| Dr. Lal Path Labs Ltd. | Mar 2026 | ▲ Increasing | +730 |
| PB Fintech Limited | Mar 2026 | ▼ Reducing | -630 |
| Divi's Laboratories Limited | Mar 2026 | ▼ Reducing | -580 |
| Jupiter Life Line Hospitals Limited | Mar 2026 | ▼ Reducing | -530 |
| Mankind Pharma Limited | Mar 2026 | ▲ Increasing | +450 |
| Neuland Laboratories Limited | Mar 2026 | ▲ Increasing | +200 |
| Abbott India Limited | Mar 2026 | ▼ Reducing | -70 |
| SAGILITY LIMITED | Feb 2026 | ▼ Reducing | -85,740 |
| PB Fintech Limited | Feb 2026 | ▼ Reducing | -3,741 |
| Lenskart Solutions Limited | Feb 2026 | ▼ Reducing | -3,470 |
| Dr. Reddy's Laboratories Limited | Feb 2026 | ▼ Reducing | -2,360 |
| Global Health Limited | Feb 2026 | ▼ Reducing | -2,220 |
| Sai Life Sciences Limited | Feb 2026 | ▼ Reducing | -2,100 |
| Rubicon Research Limited | Feb 2026 | ▼ Reducing | -1,830 |
| ICICI Lombard General Insurance Company Limited | Feb 2026 | ▼ Reducing | -1,040 |
| Sun Pharmaceutical Industries Limited | Feb 2026 | ▼ Reducing | -460 |
| Navin Fluorine International Limited | Feb 2026 | ▼ Reducing | -167 |
| Divi's Laboratories Limited | Feb 2026 | ▼ Reducing | -150 |
| Abbott India Limited | Feb 2026 | ▼ Reducing | -90 |
| Max Healthcare Institute Limited | Jan 2026 | ▼ Reducing | -12,090 |
| Aster DM Quality Care Limited | Jan 2026 | ▲ Increasing | +6,490 |
| Rainbow Childrens Medicare Limited | Jan 2026 | ▼ Complete exit | -6,055 |
| Krishna Institute of Medical Sciences Limited | Jan 2026 | ▲ Increasing | +3,610 |
| Sai Life Sciences Limited | Jan 2026 | ▲ Increasing | +3,000 |
| PB Fintech Limited | Jan 2026 | ▼ Reducing | -2,230 |
| Lenskart Solutions Limited | Jan 2026 | ▼ Reducing | -1,750 |
| ICICI Lombard General Insurance Company Limited | Jan 2026 | ▼ Reducing | -1,430 |
| Dr. Reddy's Laboratories Limited | Jan 2026 | ▼ Reducing | -1,000 |
| Global Health Limited | Jan 2026 | ▼ Reducing | -660 |
| Sun Pharmaceutical Industries Limited | Jan 2026 | ▼ Reducing | -520 |
| Divi's Laboratories Limited | Jan 2026 | ▼ Reducing | -120 |
Changes compare consecutive month-end disclosures for this portfolio only.